Database for Controls in Neuroscience Studies (D-CNS)

Database for Controls in Neuroscience Studies (D-CNS) - D-CNS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52002

Enrollment

210

Registered

2021-06-04

Start date

2021-07-09

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gezonde ontwikkeling healthy development typically developing

Interventions

None listed

Eligibility

Age

2 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. 4-18 years old; 2. Fluent Dutch speaker; 3. Inhabitant of the Netherlands.

Exclusion criteria

Exclusion criteria: 1. Absence or withdrawal of written informed consent; 2. Severe motor disability that interferes with outcome assessment; 3. Inability to comprehend testing instructions.

Design outcomes

Primary

Measure	Time frame
No primary end-point is defined for this study. Background characteristics involve demographics and medical history. Relevant outcome domains studied here involve neurophysiological, neurocognitive, behavioral and academic functioning. - Demographics and medical history will be collected using a custom questionnaire developed by the Emma Neuroscience Group. - Behavioural functioning of children and youth will be assessed using the extended version of the Strengths and Difficulties Questionnaire (SDQ) (Van Widenfelt, Goedhart, Treffers & Goodman, 2003). Besides the SDQ, the Strengths and Weaknesses of ADHD symptoms and Normal behaviour scale (SWAN; Swanson et al., 2012) will be used to assess behavioural functioning. - Cognitive functioning will be assessed using a version of the Wechsler Intelligence Scale (depending on the participants age) (Wechsler, 2002; Wechsler, 2005; Wechsler, 2008). - Neurocognitive functions will be assessed using the Emma Toolbox for Computerized Neurocognitive Testing. The Emma Toolbox is an in-house designed battery of computerized tests, presented as games, that assesses neurocognitive domains (e.g. information processing, attention, learning & memory, and visuomotor integration). - Brain activity will be measured using EEG, a non-invasive and widely used tool to assess the E-I balance. - School performance: CITO Pupil Monitoring System results will be used to assess school performance.	—

Measure

Time frame

No primary end-point is defined for this study. Background characteristics involve demographics and medical history. Relevant outcome domains studied here involve neurophysiological, neurocognitive, behavioral and academic functioning. - Demographics and medical history will be collected using a custom questionnaire developed by the Emma Neuroscience Group. - Behavioural functioning of children and youth will be assessed using the extended version of the Strengths and Difficulties Questionnaire (SDQ) (Van Widenfelt, Goedhart, Treffers & Goodman, 2003). Besides the SDQ, the Strengths and Weaknesses of ADHD symptoms and Normal behaviour scale (SWAN; Swanson et al., 2012) will be used to assess behavioural functioning. - Cognitive functioning will be assessed using a version of the Wechsler Intelligence Scale (depending on the participants age) (Wechsler, 2002; Wechsler, 2005; Wechsler, 2008). - Neurocognitive functions will be assessed using the Emma Toolbox for Computerized Neurocognitive Testing. The Emma Toolbox is an in-house designed battery of computerized tests, presented as games, that assesses neurocognitive domains (e.g. information processing, attention, learning & memory, and visuomotor integration). - Brain activity will be measured using EEG, a non-invasive and widely used tool to assess the E-I balance. - School performance: CITO Pupil Monitoring System results will be used to assess school performance.

—

Countries

Netherlands

Outcome results